Evidence map›Paper›PMID 42058493›Full record

ReviewFrontiers in cardiovascular medicine2026

A systematic review and meta-analysis of axillary intra-aortic balloon pump as a bridge to advanced heart failure therapy.

Haytham Allaham, Sara Kwiatkowski, Khalid Alswayed, Samuel Bennet, Olivia Cong, Laurence Magder, Gautam Ramani, Diljon Chahal, Mukta Srivastava, Seyed-Hossein Aalaei-Andabili and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Haytham AllahamDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Sara KwiatkowskiDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Khalid AlswayedDivision of Internal Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Samuel BennetDivision of Internal Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Olivia CongDivision of Internal Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Laurence MagderDepartment of Epidemiology & Public Health, University of Maryland Medical Center, Baltimore, MD, USA.
Gautam RamaniDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Diljon ChahalDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Mukta SrivastavaDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Seyed-Hossein Aalaei-AndabiliDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Cullen SoaresDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Anuj GuptaDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The axillary approach for intra-aortic balloon pump (IABP) placement offers an alternative to traditional transfemoral insertion, with the potential advantage of preserving mobility during temporary mechanical circulatory support. Methods: We performed a systematic review and meta-analysis of four retrospective studies evaluating outcomes in patients who received axillary IABP support. Results: Most patients supported with an axillary IABP were able to ambulate, with a pooled probability of 0.928 (95% CI: 0.811-0.999). The incidences of vascular complications (0.059; 95% CI: 0.001-0.137), stroke (0.022; 95% CI: 0.001-0.044), infection (0.037; 95% CI: 0.001-0.106), and bleeding (0.028; 95% CI: 0.005-0.052) were low. The most frequent adverse event was device failure (including kinking, rupture, migration, or malposition), with a pooled incidence of 0.314 (95% CI: 0.224-0.404). Conclusion: Axillary IABP support is a feasible bridge to advanced heart failure therapies, enabling ambulation in most patients and facilitating transition to definitive treatment. While the overall safety profile is favorable, the relatively high rate of device failure represents a key limitation of this approach.

Indexed as

advanced heart failureambulationaxillaryIABPintraaortic ballon pumpmechanical supportmetanalisys

Identifiers

PMID42058493
PMCPMC13121331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.